Eton Pharmaceuticals, Inc. (ETON)
22.32
+1.55
(+7.46%)
USD |
NASDAQ |
Mar 20, 16:00
22.25
-0.07
(-0.31%)
After-Hours: 20:00
Eton Pharmaceuticals Research and Development Expense (Quarterly) : 1.78M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 64.86M |
| Ovid Therapeutics, Inc. | 6.554M |
| Rhythm Pharmaceuticals, Inc. | 42.03M |
| Vir Biotechnology, Inc. | 85.53M |
| Sensei Biotherapeutics, Inc. | 2.533M |